[HTML][HTML] Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy

M Lecoultre, PR Walker, A El Helali - Clinical and Experimental Medicine, 2024 - Springer
Oncolytic viruses (OV) are a promising strategy in cancer immunotherapy. Their capacity to
promote anti-tumoral immunity locally raises hope that cancers unresponsive to current …

Cellular Transformation by Human Cytomegalovirus

G Herbein - Cancers, 2024 - mdpi.com
Simple Summary Discovering new oncoviruses is a main goal of virology research. In
addition to its deleterious role in immunocompromised patients and during pregnancy …

Unleashing the Potential of Natural Killer Cells in Immunotherapy for Glioblastoma and Brain Tumors

Malignant brain tumors, which are characterized by their aggressive and destructive nature,
invasive growth, and high morbidity and mortality rates, pose significant challenges for …

Myeloid Derived Suppressor Cells (MDSCs), Heme-oxygenase-1 (HO-1) and C88 expression in circulating monocytes: a study of impact on outcome in advanced …

AR Vachanaram - 2023 - iris.uniupo.it
The long-term remissions induced by immune-checkpoint inhibitors (ICIs) in many types of
cancers haveopened the possibility of a broader use of immunotherapy. Although the …